2.Prevention of contrast agent allergy in enhanced scanning
Mengda CHEN ; Yadi YIN ; Wei CUI
Chinese Journal of Biochemical Pharmaceutics 2017;37(6):238-239
Objective To study the prevention and corresponding measures for the allergy of contrast agent in scanning, and discuss the targeted prevention mode.MethodsSelection from June 2015 to August 2016, 400 cases was conducted in the people's hospital of ningbo yinzhou MR enhancement scanning patients as the research object, in the process of the study were randomly divided into control group and experimental group, 200 cases in each group.In the control group, patients were given routine procedure, including psychological counseling, diet control and health, education, etc.All patients were treated with the use of gadolinium bate as a contrast agent and intravenous injection.Compare two sets of contrast agent allergy.ResultsTwo groups of patients showed different levels of allergic reactions.The control group had five mild allergies, one moderate allergy, one severe allergy, and seven cases of allergy.There were two cases of mild allergy, 1 case of moderate allergy, no severe allergies, and 3 cases of allergies.Compared with the experimental group, the difference was statistically significant (P<0.05).ConclusionIn MR enhancement scanning to psychological counseling, diet, health education and other measures, to reduce the probability of contrast media in patients with allergic, have clinical significance.
3.Investigation and Analysis on Doctor-patientTrust in Shandong Province
Shifu CHEN ; Ruifa YIN ; Lingyun WEI
Chinese Medical Ethics 2015;(4):558-562
From the perspective of both doctors and patients, the questionnaire survey was used in 1080 medi-cal workers and patients in 12 hospitals in Shandong province.They found that is extremely development trend to the doctor-patient relationship, doctor-patient trust evaluation is relevant, doctor-patient both pay attention to the influence factors of the government and society.Both doctors in the building of doctor-patient trust, is atta-ched importance to strengthen the construction of medical ethics of medical personnel, continue to deepen the re-form of the medical system and government regulatory functions into full play.
4.Clinical Study on Fluticasone Furoate Nasal Spray in the Treatment of Allergic Rhinitis
Chen YANG ; Xinxin WEI ; Zhongpu YIN
China Pharmacy 2017;28(11):1503-1506
OBJECTIVE:To investigate clinical efficacy and safety of Fluticasone furoate nasal spray in the treatment of aller-gic rhinitis(AR). METHODS:100 AR patients in our hospital during Jan. 2014-Dec. 2015 were divided into control group and ob-servation group according to random number table,with 50 cases in each group. Both groups received decongestant Oxymetazoline hydrochloride spray. Control group was additionally given Budesonide spray,once each nostril on the first day,twice each nostril on the second day,increasing suitably according to disease condition,less than 6 times a day for patients younger than 14 years old,less than 8 times a day for patients older than 14 years old;observation group was additionally given Fluticasone furoate nasal spray,once each nostril,qd for patients younger than 14 years old,once each nostril,while morning and night for patients older than 14 years old. Both groups received treatment for consecutive 30 d. The total nasal symptoms score(TNSS),total eye symp-toms score (TESS),total nasal resistance (TNR) under 75,150 Pa,nasal minimum cross-sectional area (MCA) and the occur-rence of ADR were compared between 2 groups before and after treatment. RESULTS:There was no statistical significance in above indexes between 2 groups before treatment (P>0.05). After treatment,TNSS of 2 groups and TESS of observation group were decreased significantly compared to before treatment,and TESS of observation group was significantly lower than that of con-trol group,with statistical significance (P<0.05). There was no statistical significance in TESS of control group before and after treatment(P>0.05). TNR of 2 groups under 75,150 Pa were significantly lower than before treatment,and the observation group was lower than the control group,with statistical significance (P<0.05). MCA of 2 groups were significantly lower than before treatment,without statistical significance between 2 groups(P>0.05). The incidence of ADR in observation group was significant-ly lower than control group,with statistical significance(P<0.05). CONCLUSIONS:Fluticasone furoate is similar to budesonide in the treatment of nasal symptoms of AR patients,but it is better than budesonide in improving eye symptoms and nasal ventila-tion function with milder ADR.
5.Ultrasound ablation in the treatment of deep venous thrombosis of lower extremity
Cuiju CHEN ; Cunping YIN ; Wei FANG ;
Chinese Journal of General Surgery 2001;0(07):-
Objective To evaluate the effect of ultrasound ablation transluminally(USATL) for deep venous thrombosis(DVT) of lower extremities. Methods The clinical features of 47 patients with DVT of lower extremities treated by USATL were retrospectively analyzed. Results 5 cases were changed to surger because of a long disease course(4 months~4 years) or chronic inflammation.42 cases had satisfactory results with USATL.Among them,36 cases restored to complete return venous flow;6 had partial return flow. The symptoms and signs of 42 cases were alleviated apparently compared with pretreatment.1 case died of the rectal cancer metastasis 2 months after the treatment.Conclusions USATL can ablate DVT safely ,effectively, and conveniently.Some other transluminal angioplasties are necessary to improve the therapeutic result.
6.Low dose gabapentin abolishes ipsilateral tinnitus after peripheral facial palsy: A case report and literature review
Neurology Asia 2012;17(3):255-258
A unilateral tinnitus occurred at right ear in a hypertensive and diabetic woman shortly after an ipsilateral
peripheral facial palsy. Audiometric tests showed a predominant sensorineural hearing impairment at
right ear. Her tinnitus was abolished after an administration of a low dose of gabapentin. In view of a
controversy of gabapentin and tinnitus in previous trials, the fi ndings in this patient support that low
dose gabapentin can benefi t specifi cally the subgroup of tinnitus patient with sensorineural impairment
due to secondary contributing factor.
7.Expression of GRKs in synovial tissue from rats with collagen-induced arthritis and the effect of total glucosides of paeony
Jingyu CHEN ; Huaxun WU ; Yin CHEN ; Lingling ZHANG ; Wei WEI
Chinese Pharmacological Bulletin 1986;0(06):-
Aim To investigate the expression of GRKs in rats of synovial tissue with collagen-induced arthritis(CIA) and the effect of total glucosides of paeony.Methods SD rats were divided into six groups including normal,model,TGP(25,50,100 mg?kg-1)groups,GTW(40 mg?kg-1)group.Chicken type Ⅱ collagen was used to induce CIA in rats.The expression of GRKs was detected by Westernblot.Results The expression of GRK2,5,6 increased in model group than that in normal group.Compared with the model group,the expression of GRK2,5,6 decreased in TGP groups.Conclusion In rats of synovial tissue with CIA,the expression of GRKs was abnormal,and TGP could change the variation of GRKs which may be one of the mechanisms of TGP improvement CIA.
8.Effect of clinical pharmacist intervention on clinical rational use of antineoplastic drugs
Feng QI ; Surong CHEN ; Cunlin YIN ; Xiao WEI ; Yingping CHEN
Chinese Journal of Primary Medicine and Pharmacy 2017;24(3):358-364
Objective To explore the effect of clinical pharmacist on clinical rational use of antineoplastic drugs after participating in treatment group.Methods Retrospective research was used.According to whether there was a clinical pharmacist directly or indirectly involved in,all medical teams of the oncology department were divided into intervention group,advisory group and control group in our hospital.Intervention group was the medical team that had a specialist clinical pharmacist who could intervene irrational use of antineoplastic drug in the treatment on the spot.Advisory group was in the same area with the intervention group,and didn't have a specialist clinical pharmacist, but used to communicate with clinical pharmacist and take his medication advice,where clinical pharmacist indirectly involved in treatment.The control group was the medical group in the other area without clinical pharmacists of oncology department.The control group one and two were with the most beds among the control group.Randomly selected lung cancer,breast cancer,esophageal cancer,gastric cancer,colorectal cancer,gynecological cancer,liver/gallbladder/pancreatic cancer and other tumors patients from intervention group,advisory group,control group one and control group two,from January 2015 to December 2015,10 copies of each case,80 copies of each group.And antineoplastic drugs were commented specially.The information such as sex,age,clinical diagnosis,irrational antineoplastic drug use,adverse reaction and unexpected events and hospitalization time were recorded.Results The rate of irrational antineoplastic drug use of the intervention group (41.25%)was lower than the advisory group(80%),and was significantly lower than two control groups(147.50%,161.25%),advisory group was also lower than two control groups,but no significant differences between the two control groups(χ2 =0.193,P>0.05).Irrational chemotherapy, inappropriate usage and dosage and inappropriate indications were prominent problems in intervention group and advisory group.In addition,there were more improper solvent and contraindicated or adverse interaction problems in two control groups.Adverse events and incidence of unexpected events in intervention group (46.25%,12.50%) were significantly lower than those in two control groups[(73.75%,22.50%),(23.75%,18.75%)].Furthermore, the length of stay of intervention group patients was shortest in four groups (F=8.766,P<0.05).Conclusion By participating in the treatment group,clinical pharmacists can discover the irrational drug use and security risks in treatment,can provide medication guidance,consultation,publicity and other pharmaceutical service for specialist medical staff and patients.They will be more and more prominent in the treatment of cancer.
9.Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia.
Lin CHEN ; Xu-dong WEI ; Qin-song YIN
Chinese Journal of Hematology 2012;33(6):484-486
Aclarubicin
;
therapeutic use
;
Adolescent
;
Adult
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Cytarabine
;
therapeutic use
;
Female
;
Glutethimide
;
administration & dosage
;
analogs & derivatives
;
Granulocyte Colony-Stimulating Factor
;
therapeutic use
;
Humans
;
Leukemia, Myeloid, Acute
;
drug therapy
;
Male
;
Middle Aged
;
Treatment Outcome
;
Young Adult
10.Effects of ping-gan qianyang therapy on adrenal gland proteome in migraine rat model with hyperactivity of Hver-yang
Jianjun HU ; Zeqi CHEN ; Guangwei ZHONG ; Wei LI ; Yaohui YIN
Journal of Chinese Physician 2008;10(5):590-593
Objective To explore the molecule mechanisms of ping-gan qianyang therapy on migraine rat model with the hyperactivity of liver-yang.Methods An animal model of migraine with hyperactivity of liver-yang was established through electrical trigeminal ganglion stimulation and administering orally with Fuzi decoction.The total proteins of adrenal#and in the rats were separated by immobilized PH gradient-based two-dimensional gel electrophoresis, and the 2-DE images Was analyzed by PDQuest 7.0 software.Matrix-Assisted Laser Desorption/Ionization-Time Of Flight Mass Spectrometry(MALDI-TOF-MS)and SWISS-PORT and MSDB database were used to identify differential proteins.Result The well-resolution and reproducible 2-DE patterns of rat adrenal glands in normal group,model group and therapy group were obtained.A total of 8 differentially expressed proteins were identified.Conclusion Ping-gan qianyang therapy may effect on migraine by regulating the expression of proteins related to energy metabolism and ubiquitin.